Skip to content

A clinical study to see the effect of Ayurvedic formulations and intervention in the management of Post-Stroke Depression (PSD).

Neuro Psycho -Pharmacological study on the role of Saraswata Choorna and Madhuyashtyadi Taila Basti in the management of Post -Stroke depression.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/053232
Enrollment
120
Registered
2023-05-29
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F063- Mood disorder due to known physiological condition

Interventions

None listed

Sponsors

Dr Rajesh Jain
Lead Sponsor
Department of Kayachikitsa
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1.The post stroke patients who fulfilled the DSM-V diagnostic criteria for depressive disorder. 2.Patients ranging between the age of : 40-70 years, 3.Patients of both Sex; Male/Female, 4.The patients of Stroke caused after CVA infarct, CVA Hemorrhage will be included.

Exclusion criteria

Exclusion criteria: 1.Mood incongruent delusions or hallucinations, incoherence or marked loosening of associations. 2.Patients superimposed with schizophrenia, schizophreniform disorders, mania or bipolar disorders or psychotic disorder not otherwise specified. 3.Generalized anxiety disorders, obsessive compulsive disorders. 4.Chronic drug abuse, e.g.-barbiturates, etc. 5.Toxic abuse like alcohol ingestion and withdrawal. 6.Organic diseases like some diseases of gastrointestinal system (irritable bowel syndrome, colitis), myocardial infarction, neurodegenerative CNS diseases (e.g. Alzheimerâ??s disease), Hypothyroidism & hyperthyroidism and systemic diseases like Rheumatoid arthritis and other connective tissue disorders etc. 7.The diabetic patients with or without uncontrolled blood sugar level, or under the hypoglycaemic drugs.

Design outcomes

Primary

MeasureTime frame
1. NIH Stroke Scale (NIHSS) 2. Modified Rankin scale (mRS) 3. Hamilton Depression Rating Scale (HDRS) 4. Symptomatic GradingTimepoint: Before treatment (BT), After one month (F1), After two months (F2)and After three months of Clinical Trial (AT)

Secondary

MeasureTime frame
COMPLETE BLOOD COUNT RANDOM BLOOD SUGAR LIVER FUNCTION TEST RENAL FUNCTION TEST LIPID PROFILE NCCT HEADTimepoint: At starting (i.e. Before treatment)and at 12 week (i.e. After treatment)

Countries

India

Contacts

Public ContactDr Rajesh Jain

Banaras Hindu University

drjstripathi@rediffmail.com9838706393

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026